华民股份(300345) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥39,537,693.89, a decrease of 0.37% compared to ¥39,682,612.90 in the same period last year[3] - Net profit attributable to shareholders was ¥361,040.14, representing a significant decline of 91.52% from ¥4,257,667.83 year-on-year[3] - The company reported a net loss of CNY 205,728,538.78, slightly improved from a loss of CNY 206,089,578.92 in the previous period[15] - The net profit for Q1 2022 was CNY 101,356.74, a significant decrease compared to CNY 4,613,100.44 in Q1 2021, reflecting a decline of approximately 97.8%[18] - Operating profit for Q1 2022 was CNY -418,910.18, compared to CNY 4,291,537.10 in the same period last year, indicating a substantial loss[18] - The total comprehensive income for Q1 2022 was CNY 101,356.74, a sharp decline from CNY 4,613,100.44 in the same quarter of the previous year[18] Cash Flow and Liquidity - The net cash flow from operating activities increased by 503.69% to ¥9,809,057.91, compared to a negative cash flow of ¥2,429,820.46 in the previous year[3] - Cash flow from operating activities generated a net inflow of CNY 9,809,057.91, a recovery from a net outflow of CNY -2,429,820.46 in Q1 2021[19] - Total cash and cash equivalents at the end of Q1 2022 amounted to CNY 158,915,613.33, up from CNY 125,966,343.52 at the end of Q1 2021, representing an increase of approximately 26.2%[20] - The company experienced a net increase in cash and cash equivalents of CNY 15,610,593.86 in Q1 2022, contrasting with a decrease of CNY -3,565,509.48 in Q1 2021[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥571,569,723.56, a slight decrease of 0.29% from ¥573,229,390.34 at the end of the previous year[3] - Total assets as of March 31, 2022, were CNY 571,569,723.56, a decrease from CNY 573,229,390.34 at the beginning of the year[14] - Total liabilities decreased to CNY 58,853,141.14 from CNY 60,614,164.66, reflecting a reduction in financial obligations[14] - Cash and cash equivalents increased to CNY 158,915,613.33 from CNY 143,305,019.47, indicating improved liquidity[12] Expenses and Investments - Research and development expenses rose by 85.83% compared to the same period last year, indicating increased investment in R&D projects[5] - Research and development expenses rose significantly to CNY 613,895.79, compared to CNY 330,351.76 in the previous period, indicating a focus on innovation[16] - The company reported a 120.75% increase in financial expenses year-on-year, primarily due to a decrease in interest income[5] - Investment income increased by 142.71% year-on-year, attributed to higher returns from financial investments[5] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,967[8] - The company’s total equity stood at CNY 512,716,582.42, slightly up from CNY 512,615,225.68[15] Strategic Initiatives - The company plans to continue focusing on market expansion and product development as part of its strategic initiatives[10]